Absci Corporation (ABSI) vs Aurinia Pharmaceuticals Inc. (AUPH)
A side-by-side comparison of Absci Corporation and Aurinia Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABSI
Absci Corporation
$10.61HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
AUPH
Aurinia Pharmaceuticals Inc.
$15.73HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
Total return — ABSI vs AUPH
growth of $100 · dividends reinvested · last 5yABSI -46.6% (-11.8%/yr)AUPH +35.4% (+6.2%/yr)AUPH compounded faster over this window
ABSI AUPH
ABSI vs AUPH: by the numbers
- •AUPH is the larger company ($2.02B vs $1.80B market cap).
- •AUPH is profitable (100.84% net margin) while ABSI runs a net loss (-7756.37%).
- •AUPH grew revenue faster over the past five years (40.17% vs -22.08% CAGR).
Metrics side by side
Valuation
| Metric | ABSI | AUPH |
|---|---|---|
| P/E ratio | N/A | 6.87 |
| Forward P/E | N/A | 16.66 |
| P/S ratio | 1151.40 | 6.49 |
| P/B ratio | 7.30 | 3.29 |
| EV / EBITDA | N/A | 11.19 |
| FCF yield | N/A | 8.58% |
Profitability
| Metric | ABSI | AUPH |
|---|---|---|
| Gross margin | -319.36% | 90.36% |
| Operating margin | -4454.21% | 37.06% |
| Net margin | -7756.37% | 100.84% |
| ROE | -49.19% | 51.09% |
| ROIC | -52.66% | 21.77% |
Growth (annualized)
| Metric | ABSI | AUPH |
|---|---|---|
| Revenue CAGR (5Y) | -22.08% | 40.17% |
| Total return CAGR (5Y) | 0.89% | -5.88% |
Frequently asked
- Which has grown faster, ABSI or AUPH?
- Over the past five years, AUPH grew revenue faster — ABSI at a -22.08% CAGR versus AUPH at 40.17%.
- Is ABSI or AUPH more profitable?
- AUPH runs the higher net margin — ABSI at -7756.37% versus AUPH at 100.84%.
- How have ABSI and AUPH total returns compared?
- Over the past 5 years, ABSI delivered 0.89% and AUPH delivered -5.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Aurinia Pharmaceuticals P/E ratioAbsci ROEAurinia Pharmaceuticals ROEAbsci operating marginAurinia Pharmaceuticals operating marginAbsci revenue growthAurinia Pharmaceuticals revenue growthAbsci free cash flowAurinia Pharmaceuticals free cash flow
Absci & Aurinia Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.